About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Perseus Proteomics Inc.(4882) Summary

4882
TSE Growth
Perseus Proteomics Inc.
571
JPY
-21
(-3.55%)
Dec 23, 2:45 pm JST
3.64
USD
Dec 23, 12:45 am EST
Result
PTS
outside of trading hours
571.1
Dec 23, 2:44 pm JST
Summary Chart Historical News Financial Result
PER
PBR
4.79
Yield
ー%
Margin Trading Ratio
816.02
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
590 JPY 3.76 USD
Previous Close Dec 20
592 JPY 3.77 USD
High Dec 23, 9:00 am
593 JPY 3.78 USD
Low Dec 23, 9:27 am
565 JPY 3.61 USD
Volume
604,800
Trading Value
0.35B JPY 2.22M USD
VWAP
574.1 JPY 3.67 USD
Minimum Trading Value
57,100 JPY 364 USD
Market Cap
8.42B JPY 0.05B USD
Number of Trades
959
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
2,862
1-Year High Jul 25, 2024
20,021
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 11,100 3,878,600 349.42
Dec 6, 2024 0 3,728,100
Nov 29, 2024 100 3,651,500 36515.00
Nov 22, 2024 4,300 3,508,900 816.02
Nov 15, 2024 6,500 3,618,700 556.72
Company Profile
Perseus Proteomics Inc. is a biotech venture company specializing in the development of high-performance antibody drugs and research reagents targeting cancer.
Sector
Pharmaceuticals